MedTrace Logo

The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type II

NCT03139903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-11-20

No results posted yet for this study

Summary

The purpose of this study si to define morphological and epidemiological parameters and identify new symptoms in French patients with Seckel syndrome (SCKL) or microcephalic osteodysplastic primordial dwarfism type II (MOPDII).

Conditions

  • Microcephalic Osteodysplastic Primordial Dwarfism Type II
  • Seckel Syndrome

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • CORMIER-DAIRE Valérie, PhD · Medical Genetics Department and INSERM U781, Necker-Enfants Malades Hospital, 75743 Paris, France

Eligibility

Min Age
2 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-28
Primary Completion
2013-07-16
Completion
2015-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03139903 on ClinicalTrials.gov